Amaxa
1998
FOUNDED
M&A
STATUS
101-200
EMPLOYEES
M&A
LATEST DEAL TYPE
Description
Developer of a Nucleofector device that that is designed to transfer genes for primary cell research where non-viral gene transfer is required.
Primary Office
- Nattermannallee 1
- 50829 Cologne
- Germany
+49 0221 000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Amaxa’s full profile, request a free trial.
Amaxa Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Jul-2008 | 000.00 | Completed | Product Development | ||
| 2. Early Stage VC | 13-Jun-2001 | 000.00 | 000.00 | Completed | Product Development | |
| 1. Early Stage VC | Completed |
Amaxa Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| 3i Group | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| Earlybird Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| NRW.Bank | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Technologie-Beteiligungs-Gesellschaft | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Technomedia Kapitalbeteiligungsgesellschaft Koeln | Venture Capital | Minority | 000 0000 | 000000 0 |